HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Monika Vainorius Selected Research
Monika Vainorius Research Topics
Disease
9
Fibrosis (Cirrhosis)
01/2020 - 02/2015
6
Infections
12/2021 - 01/2016
3
Chronic Hepatitis C
12/2021 - 02/2015
3
Hepatitis C
12/2019 - 01/2017
2
Liver Diseases (Liver Disease)
12/2021 - 02/2015
1
Hepatitis
12/2021
1
End Stage Liver Disease
01/2020
1
Hepatocellular Carcinoma (Hepatoma)
10/2019
1
Liver Cirrhosis (Hepatic Cirrhosis)
10/2017
Drug/Important Bio-Agent (IBA)
6
Albumins
IBA
01/2020 - 02/2015
5
Antiviral Agents (Antivirals)
IBA
12/2021 - 01/2017
5
Ribavirin (Virazole)
FDA Link
Generic
12/2019 - 01/2016
5
Sofosbuvir
IBA
12/2019 - 01/2016
4
Bilirubin
IBA
01/2020 - 12/2016
2
sofosbuvir drug combination ledipasvir
IBA
12/2021 - 12/2016
2
ledipasvir
IBA
11/2018 - 12/2016
1
L 644711 (B-3(+))
IBA
12/2019
1
glecaprevir and pibrentasvir
IBA
12/2019
1
Serum Albumin
IBA
10/2017
1
Proton Pump Inhibitors
IBA
12/2016
1
RNA (Ribonucleic Acid)
IBA
12/2016
1
N- (3- amino- 1- (cyclobutylmethyl)- 2,3- dioxopropyl)- 3- (2- ((((1,1- dimethylethyl)amino)carbonyl)amino)- 3,3- dimethyl- 1- oxobutyl)- 6,6- dimethyl- 3- azabicyclo(3.1.0)hexan- 2- carboxamide
IBA
02/2015
1
telaprevir
IBA
02/2015
1
Creatinine
IBA
02/2015
Therapy/Procedure
6
Therapeutics
01/2020 - 02/2015
2
Aftercare (After-Treatment)
12/2019 - 12/2016
2
Liver Transplantation
10/2019 - 10/2017